MC
EXAS

Maverick Capital’s Exact Sciences EXAS Stock Holding History

Maverick Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-224
Closed -$30K – 735
2021
Q1 		$30K Buy
+224
New +$30.7K ﹤0.01% 658
2020
Q4 		– Sell
-2,296
Closed -$234K – 711
2020
Q3 		$234K Buy
+2,296
New +$198K ﹤0.01% 475
2019
Q4 		– Sell
-10,060
Closed -$909K – 369
2019
Q3 		$909K Buy
+10,060
New +$1.15M 0.01% 296

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital's EXAS Position: Q2 2021 in Review

Maverick Capital sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 224 shares — an estimated $30K sold.

Maverick Capital first reported a position in EXAS in Q3 2019 and held it in 3 quarters. The position peaked at $909K in Q3 2019. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Maverick Capital reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Maverick Capital sold 224 Exact Sciences shares in Q2 2021, an estimated $30K.
  • Maverick Capital first reported a position in Exact Sciences in Q3 2019 and held it in 3 quarters.
  • Maverick Capital's Exact Sciences position peaked at $909K in Q3 2019.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.